Skip to main content

Avenue Therapeutics, Inc.

ATXI
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001644963

No open-market purchases or sales by Avenue Therapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Avenue Therapeutics, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of ATXI: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders3429−5
Shares1.84M1.15M−685.5K (−37.3%)
Value$11.1M$2.88M−$8.26M (−74.1%)

New holders (10)

Institutions that held Avenue Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to ATXI in Q2 2021
InstitutionSharesValue% of portfolio
Renaissance Technologies LLC78,314$197.0K0.00%
Millennium Management LLC72,889$183.0K0.00%
Emfo, LLC43,590$109.0K0.10%
Advisory Services Network, LLC35,121$88.0K0.00%
Ergoteles LLC30,400$76.0K0.00%
Virtu Financial LLC26,373$66.0K0.01%
HRT Financial LP24,620$61.0K0.00%
Occudo Quantitative Strategies LP14,398$36.0K0.01%
Jane Street Group, LLC13,359$34.0K0.00%
XTX Topco Ltd10,864$27.0K0.01%

Sold out (15)

Institutions that held Avenue Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of ATXI in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
State Street Corp143,801$873.0K
Nuveen Asset Management, LLC30,629$186.0K
Invesco Ltd.16,232$99.0K
Bank of New York Mellon Corp14,848$91.0K
Charles Schwab Investment Management Inc14,314$87.0K
Trexquant Investment LP13,874$84.0K
Squarepoint Ops LLC11,668$71.0K
California State Teachers Retirement System10,047$61.0K
Deutsche Bank AG4,336$26.0K
American International Group, Inc.3,884$24.0K
Legal & General Group Plc853$5.00K
Ameritas Investment Partners, Inc.589$4.00K
Citigroup Inc443$3.00K
Berman Capital Advisors, LLC610$3.00K
Bank of Montreal216$1.00K